The first drug that slows Alzheimer’s has finally received FDA approval | Engadget
[ad_1] Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s. Leqembi received a preliminary …
The first drug that slows Alzheimer’s has finally received FDA approval | Engadget Read More »